Saurabh Kumar Das1, Nang Sujali Choupoo2, Priyam Saikia3, Amitabh Lahkar4. 1. Department of Critical Care, Fortis Super Specialty Hospital, Shalimar Bagh, New Delhi, India. 2. Department of Anesthesiology and Critical Care, Post graduate Institute of Medical Education and Research - Dr. Ram Monohar Lohia Hospital, New Delhi, India. 3. Department of Anesthesia, Milton Keynes Hospital, NHS Foundation Trust, Standing Way, Eaglestone, Milton Keynes, MK6 5HS, UK. 4. Department of Anaesthesiology and Critical Care, Gauhati Medical College and Hospital, Guwahati, Assam, India.
Abstract
INTRODUCTION: Reported incidence of acute cor pulmonale (ACP) in patients with acute respiratory distress syndrome (ARDS) varies from 10% to 84%, despite being subjected to lung protective ventilation according to the current guidelines. The objective of this review is to find pooled cumulative incidence of ACP in patients with ARDS undergoing lung protective ventilation. MATERIALS AND METHODS: We searched MEDLINE, EMBASE, Cochrane Library, KoreaMed, LILACS, and WHO Clinical Trial Registry. Cross-sectional or cohort studies were included if they reported or provided data that could be used to calculate the incidence proportion of ACP. Inverse variance heterogeneity (IVhet) and random effect model were used for the main outcome and measures. RESULTS: We included 16 studies encompassing 1661 patients. The cumulative incidence of ACP using IVhet analysis was 23% (95% confidence interval [CI] = 18%-28%) over 3 days of lung protective ventilation. Random effect analysis of 7 studies (1250 patients) revealed pooled odd ratio of mortality of 1.16 (95% CI = 0.80-1.67, P = 0.44) due to ACP. CONCLUSION: Patients with ARDS have a 23% risk of developing ACP with lung protective ventilation. Findings of this review indicate the need of updating existing guidelines for ventilating ARDS patients to incorporate right ventricle protective strategy.
INTRODUCTION: Reported incidence of acute cor pulmonale (ACP) in patients with acute respiratory distress syndrome (ARDS) varies from 10% to 84%, despite being subjected to lung protective ventilation according to the current guidelines. The objective of this review is to find pooled cumulative incidence of ACP in patients with ARDS undergoing lung protective ventilation. MATERIALS AND METHODS: We searched MEDLINE, EMBASE, Cochrane Library, KoreaMed, LILACS, and WHO Clinical Trial Registry. Cross-sectional or cohort studies were included if they reported or provided data that could be used to calculate the incidence proportion of ACP. Inverse variance heterogeneity (IVhet) and random effect model were used for the main outcome and measures. RESULTS: We included 16 studies encompassing 1661 patients. The cumulative incidence of ACP using IVhet analysis was 23% (95% confidence interval [CI] = 18%-28%) over 3 days of lung protective ventilation. Random effect analysis of 7 studies (1250 patients) revealed pooled odd ratio of mortality of 1.16 (95% CI = 0.80-1.67, P = 0.44) due to ACP. CONCLUSION:Patients with ARDS have a 23% risk of developing ACP with lung protective ventilation. Findings of this review indicate the need of updating existing guidelines for ventilating ARDSpatients to incorporate right ventricle protective strategy.
Acute respiratory distress syndrome (ARDS) is often complicated by pulmonary vascular dysfunction leading to the variable degree of right ventricular (RV) dysfunction.[1] Mechanical ventilation which is central to the management of ARDS also interferes with cardiac function by decreasing RV preload and increasing after load.[2] Strategy to open lung for optimum oxygenation remained the focus of researchers for many years. However, its effect on pulmonary vasculature and RV was largely ignored. With the advent of point of care tool, numbers of research papers were published evaluating right heart function in ARDSpatients. These studies reported very high incidence of acute cor pulmonale (ACP) due to the use of high tidal volume and high airway pressure.[3] This prompted the implementation of current guidelines of the National Heart, Lung, and Blood Institute, National Institute of Health (NIH) ARDS network mechanical ventilation protocol that recommends limiting plateau pressure (Pplat) below 30 cm H2O and positive end-expiratory pressure below 24 cm H2O.[4] The use of low volume ventilation in ARDS has reduced the incidence of ACP to some extent but could not eliminate it completely.[56] Many recent studies showed that a large number of patients still suffered from RV dysfunction and its associated mortality despite being subjected to lung protective ventilation according to the current guidelines.[5678910111213141516171819202122] However, most of these studies had small sample size and reported varied incidence of ACP ranging from 10% to 84% across the literature.[5678910111213141516171819202122] This necessitated us to undertake this systematic review of cross-sectional or cohort studies on cumulative incidence of ACP in patients with ARDS subjected to lung protective ventilation. This review was aimed for a critical appraisal of study quality and an attempt where possible to generate pooled cumulative incidence from meta-analysis.
MATERIALS AND METHODS
The method of review was decided prospectively before the commencement of the data search. The protocol was registered prospectively at the National Institute for Health Research international prospective register of systematic review (identifier CRD42017054688).[23] Amendments were made to the original protocol to calculate incidence proportion instead of prevalence. We undertook and reported our systematic review in line with the criteria outlined in the meta-analysis of observational studies in epidemiology guidelines.[24]
Data search
MEDLINE through PubMed, EMBASE through Ovid and Cochrane Library were searched from the year 2000 to 6th January 2017 using a search strategy combining keywords and related database-specific subject terms. We limited our search to the year 2000 when NIH ARDSNet Ventilator Protocol was published.[4] To retrieve further literature published in language other than English, we searched KoreaMed and LILCAS. We searched WHO Clinical Trial Registry (who.int/ictrp) to find out unpublished literature and ongoing studies. The details of search strategy are shown in the Appendix [e-Appendix 1]. New links displayed beside the online version of the published abstracts were followed and retrieved. Bibliography of retrieved articles was searched and checked for additional studies. For any confusion regarding data, the authors of the articles were contacted. We translated nonEnglish literature to English by Google Translate (https://translate.google.com/).
Selection of the studies
Any cross-sectional or cohort study that reported the incidence proportion of ACP or where incidence proportion data for ACP could be calculated was included in the meta-analysis. Studies were excluded from the analysis where the airway pressure was not limited to below 30 cm H2O during mechanical ventilation, and the study population included pediatric patients and pregnant women. The full inclusion and exclusion criteria are presented in e-Appendix 2.
Data extraction
A data extraction form was used to extract equivalent information from each study. Retrieved information were: year of publication, country of origin, study design, sample size, number of patients who suffered from ACP, the time of echocardiography examination, mortality and the definition of ARDS used. Incidence proportion with 95% confidence interval (CI) were extracted or calculated from the available data. Two authors (SD and SC) independently reviewed the articles; did quality assessment and ascertained the criteria for inclusion in the pooled data analysis. A third reviewer (PS) blinded to the primary reviewer's decision checked the article selection, data extraction, and risk of bias assessment. Any disagreement was resolved by consensus. Articles by the same author were carefully investigated to avoid duplication of studies included in the analysis.
Risk of bias assessment
Included studies were assessed for risk of bias using “JBL Critical Appraisal Checklist for Studies Reporting Prevalence Data”.[25] We assessed quality in two domains: study participation and outcome measurement. We omitted a domain about response rate, which was not relevant to our study.[25] The detailed method used for risk of bias assessment is presented in e-Appendix 3.
Analysis
Studies that met the inclusion criteria were included for meta-analysis. We conducted the meta-analysis to find out pooled incidence proportion using inverse variance heterogeneity (IVhet) under fixed-effect model assumption with a quasi-likelihood-based variance structure.[26] The proportions are transformed with double arcsine square root analysis to stabilize the variance. The incidence proportion was expressed over the period from the initiation of mechanical ventilation to the time of echocardiographic examination. Potential influence on pooled incidence proportion was investigated using subgroup analysis whenever possible. If the study permitted, odd ratio of mortality in patient with ACP was calculated using random effect model.All calculation were done using MetaXL version 5.3 (www.epigear.com, Epigear International, Sunrise Beach, Queensland, Australia) add-in for Microsoft Excel and RevMen 5.3 (Copenhagen: The Nordic Cochrane, The Cochrane Collaboration, 2014).[2728] We needed to use two different software as MetaXL alone cannot calculate odd ratio and RevMen cannot calculate pooled incidence proportion.MetaXL computes the inconsistency index (I2), which has been proposed as a measure to quantify the amount of heterogeneity. Inconsistency (I2) describes the percentage of total variation across studies that are due to heterogeneity rather than due to chance. An I2 value above 75% indicates high heterogeneity.Funnel plot and Doi plot were drawn to find out any publication bias. A quantitative measure of Doi plot asymmetry is called Luis Furuya-Kanamori (LFK) index. LFK index exceeding ±2 indicates major asymmetry.[27]
RESULTS
Our search returned a total of 9365 publications, and 44 articles were selected for full-text review. After removing correspondences, editorials, and reviews, 24 studies were read for inclusion. Finally, a total of 16 studies that fulfilled the inclusion criteria were included for quantitative analysis of pooled cumulative incidence. The review process and selection of included studies are presented in Figure 1. Email was sent to authors of two studies to know the timing of echocardiography examination. However, no reply was received.
Figure 1
The review process and selection of included studies
The review process and selection of included studiesThe included studies had a total of 1661 patients who had ARDS and subjected to lung protective ventilation. Nine studies had prospective design, and the rest were retrospective. One study also included samples of three previously published studies.[19] The incidence proportion and mortality were calculated after excluding the samples of the previously published studies. One study was published in French language; the rest were in English.The characteristics of included studies are shown in Table 1. Seven studies with 1250 patients reported mortality in patients with ACP and in patients without it.[56915161819]
Table 1
Characteristics of included studies
Characteristics of included studiesA summary of the risk of bias of the included studies is provided in Table 2. Only 25% of the studies were considered to be at low risk of bias for study participation. This was because of poor method of sampling and inadequate number of sample size.
Table 2
Risk of bias assessment of included studies
Risk of bias assessment of included studiesSeventy percent of the studies were at low risk of outcome measurement bias and used clearly defined diagnostic criteria, reliable-validated instruments, and a similar method and setting of outcome measurement for all participants.The incidence proportion ranged from 10% to 84%.[567891112131415161819202122] Three small studies reported incidence proportion more than 50%.[1213] However, majority of the studies reported an incidence proportion between 10% and 30%.[567891112131415161819202122] Sixteen estimates were included in the meta-analysis. The overall IVhet pooled incidence proportion of ACP was 23% (95% CIs = 18%–28%) with a high level of heterogeneity (I2 = 78%) [Figure 2].
Figure 2
Pooled incidence proportion of acute cor pulmonale in patients with acute respiratory distress syndrome undergoing lung protective ventilation
Pooled incidence proportion of acute cor pulmonale in patients with acute respiratory distress syndrome undergoing lung protective ventilationFunnel plot and Doi plot indicated the possibility of the presence of publication bias [e-Figures 1 and 2].
e-Figure 1
Major asymmetry in funnel plot
e-Figure 2
Significant asymmetry in Doi plot
Major asymmetry in funnel plotSignificant asymmetry in Doi plotSubgroup analysis was done excluding studies with <20 patients. Excluding two such studies that reported more than 50% incidence of ACP eliminated high level of heterogeneity [e-Figure 3].[1213] This indicated that some unpublished small studies with low incidence of ACP might be the cause of major asymmetry of the funnel and Doi plot. However, cumulative meta-analysis with decreasing sample size did not show any major change of pooled incidence proportion due to inclusion of these two small studies [e-Figure 4]. Therefore, the presence of high heterogeneity and publication bias did not have any substantial effect on the result of the meta-analysis.
e-Figure 3
Subgroup analysis after excluding two studies with sample size <20
e-Figure 4
Cumulative meta-analysis of studies with decreasing sample size
Subgroup analysis after excluding two studies with sample size <20Cumulative meta-analysis of studies with decreasing sample sizeTotal seven studies and 1250 patients were included in random effect analysis to calculate pooled odd ratio of mortality in patients with ACP.[56915161819] Out of seven studies, five showed increased mortality in patients with ACP.[56915161819] The pooled odd ratio of mortality in patients with ACP was 1.16 with 95% CI (0.80–1.67), which was not statistically significant (P = 0.44) [Figure 3].
Figure 3
Odd ratio of mortality in patient with acute cor pulmonale using random effect model
Odd ratio of mortality in patient with acute cor pulmonale using random effect model
DISCUSSION
The present systematic review and meta-analysis of 16 studies and 1661 ARDSpatients subjected to lung protective ventilation revealed that pooled incidence proportion of ACP was 23% (95% CI = 18%–28%) during 3 days of lung protective ventilation. The odd ratio of mortality with ACP was 1.16 (95% CI = 0.80–1.67).The deleterious effect of ARDS and mechanical ventilation on the right ventricle has been known for many years. ARDSNet protocol, which is in use for nearly one and half a decade, is primarily a lung protective ventilation strategy. Although lung protective ventilation improved mortality,[29] it still affects right ventricle adversely. These effects range from pulmonary artery hypertension to development of ACP.[16] This systematic review and meta-analysis give a quantitative estimation of the burden of ACP, which is the most serious form of RV dysfunction. The gold standard to diagnose pulmonary hypertension is right heart catheterization.[30] Two studies with 145 and 30 ARDSpatients, respectively, who were managed with lung protective ventilation, used pulmonary artery catheter to evaluate RV function and pulmonary hypertension. Fourteen patients in each study suffered from pulmonary hypertension.[1017]Apart from RVED/LVED ratio, there are some other echocardiographic parameters that can also be used to measure RV function, for example, tricuspid annular plane systolic excursion (TAPSE), pulsed Doppler peak velocity at the tricuspid annulus, pulsed Doppler myocardial performance index, tissue Doppler myocardial performance index, fractional areas changes.[31] About 27%–48% patients with ARDS had TAPSE <16 mm while undergoing lung protective ventilation in five studies.[1214182021]It is not very clearly known about the factors that predispose to ACP. A very high incidence of ACP was reported in studies where airway pressure was not limited.[39] One study showed that high positive end-expiratory pressure and high partial pressure of carbon dioxide were associated with the development of ACP even when Pplat was maintained below 30 cm H2O.[32] Four factors, namely, pneumonia as cause of ARDS, driving pressure >18 cm H2O (difference between plateau and total positive end-expiratory pressure measured at zero flow)[33] partial pressure of arterial oxygen/fraction of inspired oxygen <150, partial pressure of carbon dioxide >48 mmHg was found to have contributed to the development of RV dysfunction in patients with ARDS.[19]Various studies demonstrated the deleterious effect of RV dysfunction on hemodynamic. It decreases cardiac index, systolic, and mean arterial pressure. It increases heart rate, requirement of vasopressor, and incidence of shock.[1516] ACP has been found to be associated with mortality in various studies.[91015161819] However, the present study found a pooled odd ratio of mortality with ACP is 1.18, which is not statistically significant. This result may be due to the use of prone position ventilation in most of the studies that minimized the deleterious effect of ACP.[56815161819] Present evidence makes it imperative to monitor RV morphology and its function while ventilating ARDSpatients. The RV function and pulmonary circulation have been traditionally evaluated by pulmonary artery catheter. However, considering the invasiveness of the procedure and its associated complications, echocardiography can be used as an acceptable alternative.[3435] To eliminate the discontinuous nature of hemodynamic monitoring by echocardiography, a miniaturized transesophageal echocardiography probe which can be kept inserted in the patients for several days has been developed, and it has shown to provide relevant hemodynamic information.[36]In view of the potential risk associated with the current practice, it may be updated to include RV protective ventilation. This approach should include a stepwise ventilation strategy, keeping the pulmonary circulation and the right ventricle at the center of the decision-making process. It is based on the premise that “what is good for the right ventricle is also good for the lung and vice versa.”[37] This strategy may consist of limiting Pplat below 27 cm H2O, driving pressure below 17 cm H2O and PCO2 below 60 mmHg.[9193233] This strategy may also incorporate the early use of prone position ventilation or possibly extracorporeal membrane oxygenator if conventional ventilation does not meet the above criteria.[20212238] Current studies do not show evidence in support of high-frequency oscillation ventilation.[39]We observed high heterogeneity in our study which is not due to chance (I2 = 78%). This heterogeneity may be due to different etiology of ARDS (studies where ARDS was caused by pneumonia had higher incidence of ACP), use of different definition of ARDS, different timing of echocardiography examination, use of adjunct therapy such as NO inhalation, publication bias, and inclusion of studies with small sample size.This review has several strengths and limitations. This is the first review to give a quantitative summary of recent studies that examined the cumulative incidence of ACP in patients with ARDS subjected to lung protective ventilation. We conducted an extensive literature search that includes six databases. We did not limit ours search to any language. We tried to contact authors for clarification of data. Hence, we believe this review included most of the existing studies, and its result is a true reflection of cumulative incidence of ACP during mechanical ventilation of patients with ARDS. Its results, therefore, can be considered valuable addition to the present knowledge about mechanical ventilation of ARDS.This review has some methodological limitations. Many studies included in the meta-analysis are retrospective and not of very good quality. The assessment of risk of bias showed that 75% studies had moderate to high risk of bias in patient participation domain. Many studies reported their results in prevalence data which was not accurately calculated. We calculated cumulative incidence from available data since time duration from the initiation of mechanical ventilation to the diagnosis of ACP for individual patient was not available to calculate incidence. In majority of studies, echocardiography was done within 3 days of mechanical ventilation, so we expressed cumulative incidence over 3 days of time.The present systematic review and meta-analysis of 16 studies and 1661 patients revealed that patients with ARDS had a 23% (95% CI = 18%–28%) risk of developing ACP over <3 days of lung protective ventilation. This review suggests the need of updating existing guidelines for ventilating ARDSpatients to incorporate right ventricle protective strategy.
AUTHORS CONTRIBUTION
SD, SC and PS are equally responsible for the integrity of this work from inception to manuscript preparation and contribution to study design, study selection, quality assessment, records review, data synthesis, data analysis and manuscript composition. AL contributed to the review process by searching literature, reviewing search records and manuscripts. All authors read and approved the final manuscript.
Authors: Marius M Hoeper; Harm Jan Bogaard; Robin Condliffe; Robert Frantz; Dinesh Khanna; Marcin Kurzyna; David Langleben; Alessandra Manes; Toru Satoh; Fernando Torres; Martin R Wilkins; David B Badesch Journal: J Am Coll Cardiol Date: 2013-12-24 Impact factor: 24.094
Authors: A Vieillard-Baron; J M Schmitt; R Augarde; J L Fellahi; S Prin; B Page; A Beauchet; F Jardin Journal: Crit Care Med Date: 2001-08 Impact factor: 7.598
Authors: Marcelo B P Amato; Maureen O Meade; Arthur S Slutsky; Laurent Brochard; Eduardo L V Costa; David A Schoenfeld; Thomas E Stewart; Matthias Briel; Daniel Talmor; Alain Mercat; Jean-Christophe M Richard; Carlos R R Carvalho; Roy G Brower Journal: N Engl J Med Date: 2015-02-19 Impact factor: 91.245
Authors: Antoine Vieillard-Baron; Michel Slama; Paul Mayo; Cyril Charron; Jean-Bernard Amiel; Cédric Esterez; François Leleu; Xavier Repesse; Philippe Vignon Journal: Intensive Care Med Date: 2013-01-04 Impact factor: 17.440
Authors: Antoine Vieillard-Baron; Cyril Charron; Vincent Caille; Guillaume Belliard; Bernard Page; François Jardin Journal: Chest Date: 2007-10-09 Impact factor: 9.410